# A Study of QBI-139 in Subjects With Advanced Solid Tumors

> **NCT00818831** · PHASE1 · UNKNOWN · sponsor: **Quintessence Biosciences, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** QBI-139

## Key facts

- **NCT ID:** NCT00818831
- **Lead sponsor:** Quintessence Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2015-10
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00818831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00818831, "A Study of QBI-139 in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00818831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*